Showing results (71-80 of 302) with videos related to
Sort By:
Pageof 31
Clinics in Dermatology|May 26, 2004
Botulinum neurotoxin for the treatment of migraine and other primary headache disordersDavid Dodick, Andrew Blumenfeld, Stephen D SilbersteinCurrent Opinion in Neurology|March 19, 2019
The endocannabinoid system in migraine: from bench to pharmacy and backCristina Tassorelli, Rosaria Greco, Stephen D SilbersteinExpert Opinion on Pharmacotherapy|March 22, 2023
Current and emerging pharmacotherapy for menstrual migraine: a narrative reviewClaire E J Ceriani, Stephen D SilbersteinHeadache|August 9, 2002
Hemicrania continua responds to cyclooxygenase-2 inhibitorsMario F P Peres, Stephen D SilbersteinHeadache|September 24, 2005
Removing barriers to appropriate migraine treatment: formulary limitations and triptan package sizeStephen D Silberstein, David Dodick, Jim KesslickBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 27, 2022
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and RationaleFred Cohen, Hsiangkuo Yuan, Stephen D SilbersteinHeadache|October 21, 2010
Defining the pharmacologically intractable headache for clinical trials and clinical practiceStephen D Silberstein, David W Dodick, Starr PearlmanHeadache|July 11, 2019
Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative ReviewHsiangkuo Yuan, Nicole M Spare, Stephen D SilbersteinHeadache|November 19, 2019
Dihydroergotamine (DHE) - Then and Now: A Narrative ReviewStephen D Silberstein, Stephen B Shrewsbury, John HoekmanClinical Pharmacology and Therapeutics|January 17, 2019
Calcitonin Gene-Related Peptide Antagonists in the Treatment of Episodic MigraineHsiangkuo Yuan, Courtney S White, Stephen D SilbersteinPageof 31